Delta Asset Management’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$356K Hold
7,200
0.03% 127
2026
Q1
$384K Hold
7,200
0.04% 113
2025
Q4
$447K Hold
7,200
0.04% 103
2025
Q3
$433K Hold
7,200
0.04% 105
2025
Q2
$451K Hold
7,200
0.04% 101
2025
Q1
$433K Hold
7,200
0.04% 99
2024
Q4
$420K Hold
7,200
0.04% 106
2024
Q3
$426K Hold
7,200
0.04% 105
2024
Q2
$403K Hold
7,200
0.04% 102
2024
Q1
$422K Hold
7,200
0.04% 102
2023
Q4
$389K Hold
7,200
0.04% 100
2023
Q3
$349K Hold
7,200
0.04% 103
2023
Q2
$407K Hold
7,200
0.04% 98
2023
Q1
$389K Hold
7,200
0.04% 99
2022
Q4
$379K Hold
7,200
0.04% 101
2022
Q3
$340K Hold
7,200
0.04% 102
2022
Q2
$363K Hold
7,200
0.04% 100
2022
Q1
$439K Hold
7,200
0.04% 98
2021
Q4
$474K Buy
+7,200
New +$461K 0.04% 95

Other funds holding IHI

Delta Asset Management's IHI Position: Q2 2026 in Review

Delta Asset Management held its iShares US Medical Devices ETF (IHI) position steady in Q2 2026 at 7,200 shares worth $356K. The position accounts for 0.03% of the portfolio, ranked #127.

Delta Asset Management first reported a position in IHI in Q4 2021 and has held it in 19 quarters since. The position peaked at $474K in Q4 2021. 501 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

  • Delta Asset Management held 7,200 shares of iShares US Medical Devices ETF worth $356K as of Q2 2026.
  • Delta Asset Management left its iShares US Medical Devices ETF share count unchanged in Q2 2026.
  • iShares US Medical Devices ETF made up 0.03% of Delta Asset Management's portfolio in Q2 2026, its #127 holding.
  • Delta Asset Management first reported a position in iShares US Medical Devices ETF in Q4 2021 and has held it in 19 quarters since.
  • Delta Asset Management's iShares US Medical Devices ETF position peaked at $474K in Q4 2021.
  • 501 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Delta Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.